These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Should cefazolin or vancomycin be used for initial empiric coverage for Staphylococcus aureus in peritoneal dialysis associated peritonitis? Hansson JH Semin Dial; 2011; 24(4):449-50. PubMed ID: 21851410 [No Abstract] [Full Text] [Related]
32. Consensus on peritonitis treatment in pediatric patients? Schröder CH; Rusthoven E; Monnens LA Perit Dial Int; 2002; 22(1):87-9. PubMed ID: 11930942 [No Abstract] [Full Text] [Related]
33. A novel agent of peritoneal dialysis-related peritonitis: Granulicatella adiacens. Altay M; Akay H; Yildiz E; Duranay M Perit Dial Int; 2008; 28(1):96-7. PubMed ID: 18178954 [No Abstract] [Full Text] [Related]
35. The pharmacokinetics of antibiotics used to treat peritoneal dialysis-associated peritonitis. Johnson CA; Zimmerman SW; Rogge M Am J Kidney Dis; 1984 Jul; 4(1):3-17. PubMed ID: 6377882 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis. Zhu W; Fang X; Zheng J; Ke Y; He Q; Cui T; Chen B; Tian L Ren Fail; 2023; 45(2):2285873. PubMed ID: 38044852 [TBL] [Abstract][Full Text] [Related]
37. Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial. Kitrungphaiboon T; Puapatanakul P; Chuengsaman P; Tiskajornsiri K; Halue G; Siribamrungwong M; Matayart S; Chongthanakorn K; Poonvivatchaikarn U; Boonyakrai C; Somboonsilp W; Katavetin P; Praditpornsilpa K; Eiam-Ong S; Johnson DW; Kanjanabuch T Am J Kidney Dis; 2019 Nov; 74(5):601-609. PubMed ID: 31331757 [TBL] [Abstract][Full Text] [Related]
38. Clinical features, microbiological profile and treatment outcome of patients with Corynebacterium endophthalmitis: review of a decade from a tertiary eye care centre in southern India. Joseph J; Nirmalkar K; Mathai A; Sharma S Br J Ophthalmol; 2016 Feb; 100(2):189-94. PubMed ID: 26124461 [TBL] [Abstract][Full Text] [Related]
39. Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS). Schaefer F; Klaus G; Müller-Wiefel DE; Mehls O J Am Soc Nephrol; 1999 Jan; 10(1):136-45. PubMed ID: 9890319 [TBL] [Abstract][Full Text] [Related]